PT94297B - Processo para a preparacao de n-hetero-aril-purin-6-aminas e de composicoes farmaceuticas que as contem - Google Patents
Processo para a preparacao de n-hetero-aril-purin-6-aminas e de composicoes farmaceuticas que as contem Download PDFInfo
- Publication number
- PT94297B PT94297B PT94297A PT9429790A PT94297B PT 94297 B PT94297 B PT 94297B PT 94297 A PT94297 A PT 94297A PT 9429790 A PT9429790 A PT 9429790A PT 94297 B PT94297 B PT 94297B
- Authority
- PT
- Portugal
- Prior art keywords
- formula
- compound
- amine
- purin
- lower alkyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Television Signal Processing For Recording (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/363,837 US5017578A (en) | 1989-06-09 | 1989-06-09 | N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents |
Publications (2)
Publication Number | Publication Date |
---|---|
PT94297A PT94297A (pt) | 1991-02-08 |
PT94297B true PT94297B (pt) | 1997-01-31 |
Family
ID=23431950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT94297A PT94297B (pt) | 1989-06-09 | 1990-06-07 | Processo para a preparacao de n-hetero-aril-purin-6-aminas e de composicoes farmaceuticas que as contem |
Country Status (21)
Country | Link |
---|---|
US (1) | US5017578A (de) |
EP (1) | EP0402752B1 (de) |
JP (1) | JPH06102663B2 (de) |
KR (2) | KR100199524B1 (de) |
CN (1) | CN1029968C (de) |
AT (1) | ATE127807T1 (de) |
AU (1) | AU636351B2 (de) |
CA (1) | CA2018563C (de) |
DE (1) | DE69022294T2 (de) |
DK (1) | DK0402752T3 (de) |
ES (1) | ES2078267T3 (de) |
FI (1) | FI902850A0 (de) |
GR (1) | GR3017743T3 (de) |
HU (1) | HU207320B (de) |
IE (1) | IE68433B1 (de) |
IL (1) | IL94665A (de) |
MX (1) | MX21088A (de) |
NO (1) | NO902555L (de) |
NZ (1) | NZ233970A (de) |
PT (1) | PT94297B (de) |
ZA (1) | ZA904443B (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5432164A (en) * | 1991-10-24 | 1995-07-11 | Novo Nordisk A/S | C2,N6 -disubstituted adenosine derivatives |
US5319096A (en) * | 1992-04-03 | 1994-06-07 | Hoechst-Roussel Pharmaceuticals Inc. | (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use |
US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
JP3355237B2 (ja) * | 1993-10-15 | 2002-12-09 | 呉羽化学工業株式会社 | N−(置換アミノ)ピロール誘導体、その製造方法及び除草剤 |
BR9507683A (pt) * | 1994-05-10 | 1997-09-23 | Sandoz Ag | Derivados de adenosina |
US5789416B1 (en) * | 1996-08-27 | 1999-10-05 | Cv Therapeutics Inc | N6 mono heterocyclic substituted adenosine derivatives |
US6576619B2 (en) | 1999-05-24 | 2003-06-10 | Cv Therapeutics, Inc. | Orally active A1 adenosine receptor agonists |
DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
AU2004264419B2 (en) * | 2003-08-15 | 2009-01-15 | Irm Llc | 6-substituted anilino purines as RTK inhibitors |
CN100447143C (zh) * | 2003-08-15 | 2008-12-31 | Irm责任有限公司 | 作为rtk抑制剂的6-取代的苯胺基嘌呤 |
CN103259027A (zh) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | 药物信息系统 |
KR20090071598A (ko) | 2006-09-18 | 2009-07-01 | 랩터 파마슈티컬 인코포레이티드 | 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료 |
PT2398500T (pt) | 2009-02-20 | 2019-06-14 | 2 Bbb Medicines B V | Sistema de entrega de medicamentos à base de glutationas |
TWI556839B (zh) | 2009-05-06 | 2016-11-11 | 研究室護膚股份有限公司 | 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法 |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
CN104744470A (zh) * | 2014-10-31 | 2015-07-01 | 合肥平光制药有限公司 | 一种茶碱的合成方法 |
US10653681B2 (en) | 2016-03-16 | 2020-05-19 | Recurium Ip Holdings, Llc | Analgesic compounds |
CN106632339B (zh) * | 2016-12-16 | 2018-11-27 | 温州医科大学 | 一种6-取代-9h-嘌呤类衍生物及其制备方法和应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3016378A (en) * | 1959-07-01 | 1962-01-09 | Thomae Gmbh Dr K | Amino-substituted purine derivatives |
US3796700A (en) * | 1970-06-30 | 1974-03-12 | Takedo Chem Ind Ltd | Adenosine derivatives and the production thereof |
JPS4935635B1 (de) * | 1970-12-28 | 1974-09-25 | ||
US3862189A (en) * | 1973-08-14 | 1975-01-21 | Warner Lambert Co | Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents |
US3936454A (en) * | 1973-08-14 | 1976-02-03 | Warner-Lambert Company | 5-Amino-4-chloro-6-(substituted amino)-pyrimidines |
JPS57171998A (en) * | 1981-04-15 | 1982-10-22 | Fujisawa Pharmaceut Co Ltd | Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same |
US4514405A (en) * | 1981-09-17 | 1985-04-30 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Use of adenosine derivatives as anticonvulsants |
DE3406533A1 (de) * | 1984-02-23 | 1985-08-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten |
ATE50777T1 (de) * | 1984-04-18 | 1990-03-15 | Whitby Research Inc | Cardio-vasodilatatore n-6-substituierte adenosine. |
US4657897A (en) * | 1984-06-22 | 1987-04-14 | Warner-Lambert Company | N6 -substituted adenosines for treating pain |
CA1254888A (en) * | 1984-10-26 | 1989-05-30 | Bharat Trivedi | N.sup.6-bicycloadenosines |
US4752610A (en) * | 1985-12-04 | 1988-06-21 | Hoechst-Roussel Pharmaceuticals Inc. | N-(pyrrol-1-yl)pyridinamines having memory enhancing properties |
US4780452A (en) * | 1986-09-08 | 1988-10-25 | Burroughs Wellcome Co. | F-substituted-3-β-D-ribofuranosyl-3H-imidazo[4,5-b]pyridines and pharmaceutical compositions thereof |
-
1989
- 1989-06-09 US US07/363,837 patent/US5017578A/en not_active Expired - Lifetime
-
1990
- 1990-06-06 AT AT90110676T patent/ATE127807T1/de not_active IP Right Cessation
- 1990-06-06 EP EP90110676A patent/EP0402752B1/de not_active Expired - Lifetime
- 1990-06-06 DE DE69022294T patent/DE69022294T2/de not_active Expired - Lifetime
- 1990-06-06 DK DK90110676.5T patent/DK0402752T3/da active
- 1990-06-06 ES ES90110676T patent/ES2078267T3/es not_active Expired - Lifetime
- 1990-06-07 NZ NZ233970A patent/NZ233970A/xx unknown
- 1990-06-07 FI FI902850A patent/FI902850A0/fi not_active Application Discontinuation
- 1990-06-07 IL IL9466590A patent/IL94665A/en not_active IP Right Cessation
- 1990-06-07 PT PT94297A patent/PT94297B/pt not_active IP Right Cessation
- 1990-06-08 NO NO90902555A patent/NO902555L/no unknown
- 1990-06-08 HU HU903768A patent/HU207320B/hu not_active IP Right Cessation
- 1990-06-08 IE IE207790A patent/IE68433B1/en not_active IP Right Cessation
- 1990-06-08 JP JP2148884A patent/JPH06102663B2/ja not_active Expired - Fee Related
- 1990-06-08 CA CA002018563A patent/CA2018563C/en not_active Expired - Fee Related
- 1990-06-08 ZA ZA904443A patent/ZA904443B/xx unknown
- 1990-06-08 AU AU56919/90A patent/AU636351B2/en not_active Expired - Fee Related
- 1990-06-08 CN CN90104194A patent/CN1029968C/zh not_active Expired - Fee Related
- 1990-06-08 MX MX2108890A patent/MX21088A/es unknown
- 1990-06-09 KR KR1019900008444A patent/KR100199524B1/ko not_active IP Right Cessation
-
1995
- 1995-10-16 GR GR950402843T patent/GR3017743T3/el unknown
-
1998
- 1998-11-17 KR KR1019980049161A patent/KR100210179B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IE902077L (en) | 1990-12-09 |
KR100210179B1 (ko) | 1999-07-15 |
GR3017743T3 (en) | 1996-01-31 |
DE69022294T2 (de) | 1996-03-14 |
ES2078267T3 (es) | 1995-12-16 |
KR100199524B1 (ko) | 1999-06-15 |
EP0402752B1 (de) | 1995-09-13 |
JPH0324080A (ja) | 1991-02-01 |
HU207320B (en) | 1993-03-29 |
US5017578A (en) | 1991-05-21 |
CA2018563A1 (en) | 1990-12-09 |
CN1029968C (zh) | 1995-10-11 |
JPH06102663B2 (ja) | 1994-12-14 |
NZ233970A (en) | 1993-02-25 |
MX21088A (es) | 1993-11-01 |
DK0402752T3 (da) | 1996-01-15 |
IE68433B1 (en) | 1996-06-12 |
KR910000730A (ko) | 1991-01-30 |
EP0402752A1 (de) | 1990-12-19 |
HU903768D0 (en) | 1990-11-28 |
HUT54156A (en) | 1991-01-28 |
CN1047866A (zh) | 1990-12-19 |
FI902850A0 (fi) | 1990-06-07 |
IL94665A0 (en) | 1991-04-15 |
IL94665A (en) | 1994-06-24 |
NO902555D0 (no) | 1990-06-08 |
NO902555L (no) | 1990-12-10 |
PT94297A (pt) | 1991-02-08 |
AU636351B2 (en) | 1993-04-29 |
DE69022294D1 (de) | 1995-10-19 |
ZA904443B (en) | 1991-03-27 |
CA2018563C (en) | 2000-09-19 |
ATE127807T1 (de) | 1995-09-15 |
AU5691990A (en) | 1990-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT94297B (pt) | Processo para a preparacao de n-hetero-aril-purin-6-aminas e de composicoes farmaceuticas que as contem | |
KR100667645B1 (ko) | 환상 아민 ccr3 길항제 | |
JP3514490B2 (ja) | トリフルオロメチルピロロインドールカルボン酸エステル誘導体及びその製造方法 | |
KR20070011483A (ko) | Ikb 키나제 억제제로서의 실질적으로 순수한2-{[2-(2-메틸아미노-피리미딘-4-일)-1h-인돌-5-카르보닐]-아미노}-3-(페닐피리딘-2-일-아미노)-프로피온산 | |
SK404291A3 (en) | INDOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION COMPRISING THEMì (54) AND THEIR USE | |
KR20140059164A (ko) | 트라이사이클릭 자이라제 억제제 | |
TW201625618A (zh) | 抑制瞬時受體電位a1離子通道 | |
US20240092757A1 (en) | HETEROARYL DIAMIDE IRE1/XBP1s ACTIVATORS | |
WO2023088418A1 (en) | Compounds as sars-cov-2 inhibitors | |
EP0389984A1 (de) | Carbonate des Eserolins, ein Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel | |
PT95579A (pt) | Processo de preparacao de 1,2,3,4-tetra-hidro-isoquinolinas 6-substituidas e de composicoes farmaceuticas que as contem | |
CN104610233B (zh) | 具有更高蛋白激酶g抑制活性的化合物及其制备方法 | |
EP0425669B1 (de) | 1-amino-5-halogenouracile, verfahren zu deren herstellung und diese enthaltende cns-depressiva | |
US20070142417A1 (en) | Substantially Pure 2-{[2-(2-Methylamino-Pyrimidin-4-YL)-1H-Indole-5-Carbonyl]-Amino}-3-Phenylpyridin-2-YL-Amino)-Propionic Acid as an IkB Kinase Inhibitor | |
WO2019001307A1 (zh) | 一种酰胺类化合物及包含该化合物的组合物及其用途 | |
US11814371B2 (en) | Heterocyclic compound | |
WO2022125614A1 (en) | Phosphonates as inhibitors of enpp1 and cdnp | |
JPS6230762A (ja) | 新規5−オキソ−1−イミダゾリジンアセトアミド誘導体 | |
ES2312968T3 (es) | Compuestos novedosos. | |
US5155098A (en) | N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them | |
CN115536696B (zh) | Enpp1抑制剂 | |
CN102666563A (zh) | 作为a2a受体激动剂的烷氧基羰基氨基炔基腺苷化合物及其衍生物 | |
TW201302736A (zh) | 組織蛋白酶(Cathepsin)C抑制劑 | |
US6630477B1 (en) | Therapeutic nucleoside compound | |
WO2022125613A1 (en) | Phosphonates as inhibitors of enpp1 and cdnp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Patent granted, date of granting |
Effective date: 19961007 |
|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20040430 |